The Evolution Of Drug Regulation In Post-Brexit Britain

Regulatory reliance is playing an increasingly important role in gaining marketing authorization in the UK following Brexit. Meanwhile, the country’s unique Innovative Licensing and Access Pathway is attracting growing levels of interest, not just from companies but from regulators and health technology appraisal bodies across the world.

UK Drugs
The UK's ILAP aims to marry regulatory and HTA processes to deliver quicker market access for drugs • Source: Shutterstock

More from United Kingdom

More from Europe